School of Medicine
Showing 481-490 of 1,084 Results
-
Youn H Kim, MD
The Joanne and Peter Haas, Jr., Professor for Cutaneous Lymphoma Research and Professor, by courtesy, of Medicine (Oncology)
Current Research and Scholarly InterestsClinical research in cutaneous lymphomas, especially, mycosis fungoides; studies of prognostic factors, long-term survival results, and effects of therapies. Collaborative research with Departments of Pathology and Oncology in basic mechanisms of cutaneous lymphomas. Clinical trials of new investigative therapies for various dermatologic conditions or clinical trials of known therapies for new indications.
-
Abby C. King
David and Susan Heckerman Professor and Professor of Epidemiology & Population Health and of Medicine (Stanford Prevention Research Center)
Current Research and Scholarly InterestsMy interests include applications of behavioral theory and social ecological approaches to achieve large scale changes impacting chronic disease prevention and control; expanding the reach and translation of evidence-based interventions through state-of-the-art technologies; exploring social and physical environmental influences on health; applying community participatory research perspectives to address health disparities; and policy-level approaches to health promotion/disease prevention.
-
Teri Klein
Professor (Research) of Biomedical Data Science, of Medicine (BMIR) and, by courtesy, of Genetics
Current Research and Scholarly InterestsCo-founder, Pacific Symposium on Biocomputing
NIEHS, Site Visit Reviewer
NIH, Study Section Reviewer -
Joshua W. Knowles
Associate Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsGenetic basis of coronary disease
Genetic basis of insulin resistance
Familial Hypercholesterolemia (FH) -
Matthew Kohrman
Associate Professor of Anthropology, and by courtesy, of Medicine (Stanford Prevention and Research Center) and Senior Fellow, by courtesy, at the Freeman Spogli Institute for International Studies
BioMatthew Kohrman’s research and writing bring anthropological methods to bear on the ways health, culture, and politics are interrelated. Focusing on the People's Republic of China, he engages various intellectual terrains such as governmentality, gender theory, political economy, critical science studies, narrativity, and embodiment. His first monograph, Bodies of Difference: Experiences of Disability and Institutional Advocacy in the Making of Modern China, raises questions about how embodied aspects of human existence, such as our gender, such as our ability to propel ourselves through space as walkers, cyclists and workers, become founts for the building of new state apparatuses of social provision, in particular, disability-advocacy organizations. Over the last decade, Prof. Kohrman has been involved in research aimed at analyzing and intervening in the biopolitics of cigarette smoking among Chinese citizens. This work, as seen in his recently edited volume--Poisonous Pandas: Chinese Cigarette Manufacturing in Critical Historical Perspectives--expands upon heuristic themes of his earlier disability research and engages in novel ways techniques of public health, political philosophy, and spatial history. More recently, he has begun projects linking ongoing interests at the intersection of phenomenology and political economy with questions regarding environmental attunement and the arts.
-
Michael Kozal
Senior Associate Dean for Veterans Affairs and Professor of Medicine (Infectious Diseases)
BioDr. Kozal was appointed Senior Associate Dean for Veteran Affairs at Stanford School of Medicine and Chief of Staff at VA Palo Alto Health Care System in 2021. Prior to coming to Stanford, he served as Associate Dean for Veteran Affairs at Yale University School of Medicine and the Chief of Staff at VA Connecticut Healthcare System.
Dr. Kozal is a translational researcher who has focused his research career on three areas: 1) investigating the genetic determinants of HIV and HCV drug resistance, 2) the development of new molecular methods to detect viral mutations, and 3) HIV and HCV clinical trials involving new drugs and diagnostic technology. Dr. Kozal is an expert in microarray and deep sequencing technology receiving patents for his work in genotyping. Dr. Kozal previously directed the Yale HIV Clinical Trials Group and has more than 20 years of experience in running clinical trials, serving as the principal investigator or site investigator on >40 HIV and Hepatitis C trials. He has served on multiple VA and NIH/NCI review panels and is a current a member of the DHHS/NIH Panel on Antiretroviral Guidelines for Adults and Adolescents.